Latest in Biogen’s stock hit by soft sales of Alzheimer’s treatment
Sort by
1,772 items
-
Biogen’s stock hit by soft sales of Alzheimer’s treatment
“We continue to see momentum with ongoing product launches and we are increasingly excited about the potential of our pipeline,” the company’s CEO said.Business - MarketWatch - October 30 -
Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug
Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease drug that the company developed with Japanese partner Eisai — reversing ...Business - MarketWatch - November 14 -
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company's multiple sclerosis products.Business - CNBC - October 30 -
Costco shoppers stocked up on supplies as hurricanes, port strike hit. The trend hurt sales in October.
The warehouse retailer says demand was “negatively affected” by “abnormal consumer activity” tied to the September events.Business - MarketWatch - November 7 -
4 retail stocks that look good even if the holiday shopping season is soft
Wall Street research firm Telsey Advisory Group is upbeat on Costco, Amazon, Best Buy and TJX Companies.Business - CNBC - November 2 -
Western consumer groups unconvinced by China’s economic stimulus efforts
Falling sales for luxury, beauty and beer companies fuel doubts about Beijing’s attempts to boost confidenceBusiness - Financial Times - October 31 -
Mercedes-Benz and Porsche look for cost cuts after China slump hits profits
German carmakers exposed to Asian nation’s economic malaise after benefiting from its booming auto marketBusiness - Financial Times - October 25 -
Stellantis hit by sales slide in US and Europe
Fiat, Jeep and Peugeot owner suffers 27% drop in third-quarter sales but signals improvement to US inventoryWorld - Financial Times - October 31 -
This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho
Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...Business - MarketWatch - November 14 -
Amazon launches fixed pricing for treatment of conditions such as hair loss. Hims & Hers stock drops 24%
Amazon announced Prime members can access new upfront pricing for treatment of five common conditions such as erectile disfunction and men's hair loss.Business - CNBC - November 14 -
Vaccine stocks hit by RFK Jr nomination
GSK, Sanofi and Moderna shares all sink after Donald Trump chooses vaccine sceptic as top US health officialBusiness - Financial Times - November 15 -
Apple Sales Hit Quarterly Record as iPhone Business Rebounds
Apple reported revenue reached an all-time high for the September quarter, propelled by a modest rebound in iPhone sales that came ahead of its release of new artificial-intelligence tools.Business - The Wall Street Journal - October 31 -
Russian sales of Chinese cars surge after western sanctions hit
Purchases of vehicles from Asian nation’s automakers reach fresh records as Russians ‘vote with their wallets’World - Financial Times - November 15 -
Shop sales in surprise fall as Budget fears hit spending
Sales volumes fell by more than expected in October with clothing stores having a "notably poor" month.Top stories - BBC News - Yesterday -
Chipotle’s new CEO maintains focus on faster service as sales fall short
Shares of Chipotle Mexican Grill Inc. fell after hours on Tuesday after the Mexican fast-casual chain reported quarterly sales trends that were a bit weaker than expected.Business - MarketWatch - October 30 -
Caterpillar’s stock falls as weak equipment sales lead to a rare profit miss
Caterpillar’s stock fell after a rare profit miss, while revenue was below expectations for a fourth straight quarter.Business - MarketWatch - October 30 -
Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?
Eli Lilly’s stock heads for biggest selloff in more than three years after sales of anti-obesity drugs Mounjaro and Zepbound came up well short of forecasts.Business - MarketWatch - October 30 -
EBay’s sales outlook comes in weaker, and stock falls more than 7%
EBay’s slightly better-than-expected quarterly earnings were no match for a weaker sales outlook.Business - MarketWatch - October 31 -
Wendy’s stock falls as same-restaurant sales miss again, by a wide margin
Shares of Wendy’s Co. were knocked lower on Thursday after the fast-food burger chain missed same-restaurant sales expectations again, by the widest margin in more than four years.Business - MarketWatch - October 31 -
Tapestry’s stock climbs on sales and earnings beat, raised outlook
Tapestry’s first-quarter revenue was fueled by topline growth at Coach.Business - MarketWatch - November 7 -
WK Kellogg’s stock soars as strength in granola and premium cereals boosts sales
WK Kellogg Co.’s stock was enjoying a record rally on Thursday, after the cereal company beat third-quarter earnings expectations as strength in premium granola sales helped mitigate ...Business - MarketWatch - November 7 -
Walmart sales beat again and outlook raised, as retailer cites ‘resilient’ US customers
Walmart’s stock headed for a record after another earnings beat, as general merchandise sales turned positive.Business - MarketWatch - 3 days ago -
Target Stock Plunges After Weak Earnings Report Ahead of Holiday Season
The retailer’s downbeat earnings report, which included lower profit and larger inventory, fell far short of Wall Street’s expectations.Business - The New York Times - 2 days ago -
Alphabet’s stock slides as Feds push for Chrome sale. Why fears are overblown.
The Google parent’s stock is heading for its worst day in 10 months. But one analyst thinks a forced Chrome sale seems unlikely.Business - MarketWatch - Yesterday -
Ozempic lowers Alzheimer’s risk: Research
The diabetes and weight loss drug Ozempic could lower the risk of Alzheimer's disease among people with Type 2 diabetes, according to a new study published Thursday. Alzheimer’s disease is the ...Politics - The Hill - October 24 -
HCA Healthcare’s stock slides 9% after earnings are weighed down by Hurricane Helene
HCA is expecting Hurricane Helene’s impact on facilities in North Carolina and Hurricane Milton’s impact on facilities in Florida in October to shave 60 cents to 90 cents off fourth-quarter EPS.Business - MarketWatch - October 25 -
European stocks hit by ‘Trump effect’ as odds tilt towards Republican win
Former president’s promise of tariffs has dragged down sectors already struggling with flagging Chinese demandBusiness - Financial Times - October 27 -
US stocks hit record and investors dump bonds after Trump victory
Dollar rallies in its best day in 2 years as ‘Trump trades’ sweep through global marketsWorld - Financial Times - November 6 -
Overnight stock trading hit a record high on the night of the U.S. election
Brokerages that offer overnight and 24-hour trading saw a surge in volume on the night of the U.S. election.Business - MarketWatch - November 7 -
U.K. government bond yields hit 2024 highs as traders balk at increased debt sales
Benchmark U.K. bond yields hit their highs of the year on Thursday as investors balked at the increased borrowing set out in the government’s budget.Business - MarketWatch - October 31 -
First-time home buyers’ share of home sales hits 43-year low, real-estate group says
It has never been this challenging to be a first-time home buyer.Business - MarketWatch - November 5 -
Chancellor and BoE governor call for UK to rebuild ties with EU
Reeves and Bailey highlight damage from Brexit amid concern about Trump’s plan to impose tariffs on trading partnersBusiness - Financial Times - November 14